Literature DB >> 15703896

Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation.

Gabriel Malerba1, Florence Romano-Girard, Aurélie Cravoisy, Brigitte Dousset, Lionel Nace, Bruno Lévy, Pierre-Edouard Bollaert.   

Abstract

OBJECTIVE: To study the factors associated with relative adrenocortical deficiency in mechanically ventilated, critically ill patients. DESIGN AND
SETTING: Prospective observational study in a multidisciplinary ICU of a university-affiliated teaching hospital. PATIENTS: Sixty-two consecutive, acutely ill patients needing mechanical ventilation for more than 24 h. MEASUREMENTS AND
RESULTS: A high-dose short corticotropin test 24 h after endotracheal intubation. Relative adrenocortical deficiency ("nonresponder" group of patients) was defined by a rise in cortisol less than 90 microg/l after stimulation. Twenty-seven patients were classified as nonresponders and 35 as responders. On univariate analysis nonresponders were more often men, had lower mean arterial pressure, required vasoactive agents more often, had lower creatinine clearance, higher SAPS II, higher organ dysfunction scores, and received etomidate as a single bolus for endotracheal intubation more often than responders. On multivariate analysis, only etomidate administration was related to relative adrenocortical deficiency (OR 12.21; 95% CI 2.99-49.74) while female gender was protective (OR 0.13; 95% CI 0.03-0.57).
CONCLUSIONS: A single bolus infusion of etomidate could be a major risk factor for the development of relative adrenocortical deficiency in ICU patients for at least 24 h after administration. Female gender is an independent protective factor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15703896     DOI: 10.1007/s00134-004-2550-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  27 in total

Review 1.  Corticosteroid insufficiency in acutely ill patients.

Authors:  Mark S Cooper; Paul M Stewart
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

2.  Unraveling the mystery of adrenal failure in the critically ill.

Authors:  Paul E Marik
Journal:  Crit Care Med       Date:  2004-02       Impact factor: 7.598

Review 3.  Relative adrenal failure in intensive care: an identifiable problem requiring treatment?

Authors:  A Beishuizen; L G Thijs
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2001-12       Impact factor: 4.690

4.  Pituitary-adrenal axis function in systemic inflammatory response syndrome.

Authors:  J A Tayek; V J Atienza
Journal:  Endocrine       Date:  1995-05       Impact factor: 3.633

5.  Testosterone receptor blockade after trauma-hemorrhage improves cardiac and hepatic functions in males.

Authors:  D E Remmers; P Wang; W G Cioffi; K I Bland; I H Chaudry
Journal:  Am J Physiol       Date:  1997-12

6.  Adrenocortical function in critically ill patients 24 h after a single dose of etomidate.

Authors:  A Absalom; D Pledger; A Kong
Journal:  Anaesthesia       Date:  1999-09       Impact factor: 6.955

7.  APACHE-acute physiology and chronic health evaluation: a physiologically based classification system.

Authors:  W A Knaus; J E Zimmerman; D P Wagner; E A Draper; D E Lawrence
Journal:  Crit Care Med       Date:  1981-08       Impact factor: 7.598

8.  EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units.

Authors:  C Brun-Buisson; P Meshaka; P Pinton; B Vallet
Journal:  Intensive Care Med       Date:  2004-03-02       Impact factor: 17.440

9.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

10.  Mortality amongst multiple trauma patients admitted to an intensive therapy unit.

Authors:  I Watt; I M Ledingham
Journal:  Anaesthesia       Date:  1984-10       Impact factor: 6.955

View more
  49 in total

1.  Etomidate increases susceptibility to pneumonia in trauma patients.

Authors:  Karim Asehnoune; Pierre Joachim Mahe; Philippe Seguin; Samir Jaber; Boris Jung; Christophe Guitton; Nolwen Chatel-Josse; Aurelie Subileau; Anne Charlotte Tellier; Françoise Masson; Benoit Renard; Yannick Malledant; Corinne Lejus; Christelle Volteau; Véronique Sébille; Antoine Roquilly
Journal:  Intensive Care Med       Date:  2012-07-10       Impact factor: 17.440

2.  ICU physicians should abandon the use of etomidate!

Authors:  Djillali Annane
Journal:  Intensive Care Med       Date:  2005-01-27       Impact factor: 17.440

3.  Adrenal axis function does not appear to be associated with hemodynamic improvement in septic shock patients systematically receiving glucocorticoid therapy.

Authors:  Jerome Morel; Christophe Venet; Yannis Donati; David Charier; Jerome Liotier; Delphine Frere-Meunier; Stephane Guyomarc'h; Eric Diconne; Jean Claude Bertrand; Bertrand Souweine; Laurent Papazian; Fabrice Zeni
Journal:  Intensive Care Med       Date:  2006-06-20       Impact factor: 17.440

Review 4.  The effect of etomidate on adrenal function in critical illness: a systematic review.

Authors:  Stewart G Albert; Srividya Ariyan; Ayesha Rather
Journal:  Intensive Care Med       Date:  2011-03-04       Impact factor: 17.440

5.  Relative adrenal insufficiency and hemodynamic status in cardiopulmonary bypass surgery patients. A prospective cohort study.

Authors:  José L Iribarren; Juan J Jiménez; Domingo Hernández; Lisset Lorenzo; Maitane Brouard; Antonio Milena; María L Mora; Rafael Martínez
Journal:  J Cardiothorac Surg       Date:  2010-04-19       Impact factor: 1.637

6.  Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version.

Authors:  Jörg Martin; Anja Heymann; Katrin Bäsell; Ralf Baron; Rolf Biniek; Hartmut Bürkle; Peter Dall; Christine Dictus; Verena Eggers; Ingolf Eichler; Lothar Engelmann; Lars Garten; Wolfgang Hartl; Ulrike Haase; Ralf Huth; Paul Kessler; Stefan Kleinschmidt; Wolfgang Koppert; Franz-Josef Kretz; Heinz Laubenthal; Guenter Marggraf; Andreas Meiser; Edmund Neugebauer; Ulrike Neuhaus; Christian Putensen; Michael Quintel; Alexander Reske; Bernard Roth; Jens Scholz; Stefan Schröder; Dierk Schreiter; Jürgen Schüttler; Gerhard Schwarzmann; Robert Stingele; Peter Tonner; Philip Tränkle; Rolf Detlef Treede; Tomislav Trupkovic; Michael Tryba; Frank Wappler; Christian Waydhas; Claudia Spies
Journal:  Ger Med Sci       Date:  2010-02-02

7.  Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)).

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte
Journal:  Ger Med Sci       Date:  2010-06-28

8.  Cardiac effects of induction agents in the septic rat heart.

Authors:  York A Zausig; Hendrik Busse; Dirk Lunz; Barbara Sinner; Wolfgang Zink; Bernhard M Graf
Journal:  Crit Care       Date:  2009-09-08       Impact factor: 9.097

9.  Does remifentanil shorten ventilator maintenance, midozolam prolong it, or both alter its duration?

Authors:  Harry W Daniell
Journal:  Intensive Care Med       Date:  2009-06-17       Impact factor: 17.440

10.  One single dose of etomidate negatively influences adrenocortical performance for at least 24h in children with meningococcal sepsis.

Authors:  Marieke den Brinker; Anita C S Hokken-Koelega; Jan A Hazelzet; Frank H de Jong; Wim C J Hop; Koen F M Joosten
Journal:  Intensive Care Med       Date:  2007-08-21       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.